Folic acid antagonists during pregnancy and the risk of birth defects

Article Abstract:

Folic acid alone may lower the risk of birth defects, as shown by a study of 6,932 babies whose mothers took drugs that inhibit folic acid formation while they were pregnant. Compared to 8,387 other babies, the babies exposed to folic acid inhibitors had two to three times the risk of birth defects.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn

Article Abstract:

A study is conducted to see whether persistent pulmonary hypertension of the newborn (PPHN) is associated with substantial infant mortality and morbidity. The results show that neither the use of selective serotonin-reuptake inhibitors (SSRIs) before the 20th week of gestation nor the use of non-SSRI antidepressant drugs at any time during pregnancy was associated with an increased risk of PPHN.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

First trimester use of selective serotinin-reuptake inhibitors and the risk of birth defects

Article Abstract:

The article records findings of a large scale control study on the use of serotonin reuptake inhibitors during the first three months of pregnancy and possible congenital birth defects.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: